Dr. Michael Lewitton, MD

Dr. Lewitton practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Lewitton's NPI, 1558313692, was assigned on May 17, 2006. Dr. Lewitton graduated from Vagelos College of Physicians and Surgeons in 1994. Dr. Lewitton holds Texas license K1236.

Dr. Lewitton's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Lewitton's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Lewitton is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Metro Urology. Dmand AI also links Dr. Lewitton to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lewitton practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lewitton's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lewitton is board certified in urology by the American Board of Urology. Dr. Lewitton is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Lewitton treats.

CMS data shows 16,024 Medicare services from Dr. Lewitton across 32 procedure codes in 2024, for 1,046 Medicare patients. Medicare paid $427,204 for them.

CMS counts 1,046 Medicare patients who saw Dr. Lewitton in 2024. The largest group is 65 to 74, with 522 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lewitton's median patient age at 70, with 10% women.

In 2024, Dr. Lewitton wrote 3,285 Medicare Part D claims for 815 patients. 91% of them were for generic drugs. CMS names the drug for 3,098 of them, across 31 drugs with 11 or more claims each, at $1,254,075 in total drug cost. In 2023, CMS named 2,873 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Lewitton for performance year 2024, reported as part of a group. Dr. Lewitton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lewitton as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Lewitton, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Lewitton. Dr. Lewitton's most frequent co-authors are Garrett Lynch, MD, Suleiman Alfred Massarweh, MD and Uday R. Popat, MD.

CMS Open Payments shows 898 general payments to Dr. Lewitton from 83 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. HMU Consumables, LLC paid the most, $5,143.

Dmand AI lists 4 awards for Dr. Lewitton, most recently ACS Fellow in 2011.

Dr. Lewitton graduated from Vagelos College of Physicians and Surgeons in 1994. Dr. Lewitton is a member of ACS.

Dr. Lewitton is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.